CJC-1295 + Ipamorelin (No Dac) 5mg+5mg blend

This listing supplies CJC-1295 and Ipamorelin as a single co-formulated research preparation — two distinct synthetic peptides lyophilized together into one vial for in-vitro and preclinical laboratory work. CJC-1295 is a synthetic analog of the growth-hormone-releasing hormone (GHRH) sequence, built on the GRF(1-29) fragment with substituted residues that increase its resistance to enzymatic breakdown in aqueous and plasma-model conditions. Ipamorelin is a short synthetic pentapeptide (Aib-His-D-2-Nal-D-Phe-Lys-NH2) classified in the literature as a growth-hormone secretagogue that acts, in cell-based systems, at the ghrelin/GHS-R1a receptor rather than at the GHRH receptor. Because the two peptides engage separate receptor systems in vitro, they are frequently studied as a pair, and this blend supplies them pre-combined at a fixed ratio for that purpose.